3,7,11,15-Tetramethylhexadec-2-en-1-ol, 95.0%, 100g

4-Bromo-5-chloro-2-fluorobenzene sulfonamide, 1g

tert-Butyl (5-(bromomethyl)pyrazin-2-yl)carbamate, 95.0%, 250mg

Ethyl 4-chloroimidazo[1,5-a]quinoxaline-3-carboxylate, 95%, 250mg

ETHYL QUINUCLIDINE-4-CARBOXYLATE HCL, 95.0%, 500mg

Br-Mmc (=4-Bromomethyl-7-methoxycoumarin) [for HPLC Labeling]>98.0%(T)1g

2H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-amine dihydrochloride, 98%, 250mg

4,5-DIHYDRO-1H-IMIDAZOLE-2-SULFONIC ACID, 98.0%, 250mg

2,2'-Oxybis(N,N-di-n-octylacetamide)>95.0%(GC)250mg

2-(3-(Difluoromethyl)-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 250mg

2-{2-Methyl-5-[4-(methylsulfanyl)phenyl]-1H-pyrrol-1-yl}ethan-1-ol, 98%, 1g

3-(tert-Butyl) 4-methyl (2S,4R)-2-(tert-butyl)oxazolidine-3,4-dicarboxylate, 98%, 250mg

tert-Butyl-4-hydroxybutyrate, 97.0%, 100mg